ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,998Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 1290

$3.65M Total Retail Price of All Prescriptions

Rank: 3 out of 1290

178 Patients Receiving at Least One Drug in Part D
26%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 178 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 178 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 1,134 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

54% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$456 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
EPZICOM 402 59 10 1 283
VALACYCLOVIR 312 27 10 2 322
NORVIR 269 12 3 163
ACYCLOVIR 248 39 4 282
ISENTRESS 244 32 5 220
ENALAPRIL MALEATE 210 69 6 62
TRUVADA 200 22 7 180
TRILIPIX 194 12 8 313
REYATAZ 193 0 9 285
KALETRA 166 21 10 334
ATORVASTATIN CALCIUM 158 19 11 23
ATRIPLA 139 13 12 257
CRESTOR 136 0 13 17
SUSTIVA 125 16 14 366
ACTOS 120 20 15 182
INTELENCE 111 0 16 331
SELZENTRY 108 0 17 406
MIRTAZAPINE 107 0 18 93
GABAPENTIN 105 28 19 8
CLONIDINE HCL 97 0 20 66
METFORMIN HCL 96 0 21 10
LAMIVUDINE 91 0 22 432
ATENOLOL 89 28 23 18
VIRAMUNE XR 85 11 24 544
TRIZIVIR 85 13 10 24 486
LEXIVA 83 12 26 424
INVIRASE 69 0 10 27 473
PIOGLITAZONE HCL 65 19 R 28 326
METOPROLOL TARTRATE 62 0 29 7
OMEPRAZOLE 59 14 30 2
ZOLPIDEM TARTRATE 58 0 31 15
LIPITOR 57 0 32 195
VIREAD 57 0 32 330
SIMVASTATIN 57 27 32 1
MORPHINE SULFATE ER 55 0 S2 35 55
LOVAZA 55 0 35 131
LEVOTHYROXINE SODIUM 52 0 37 4
LAMIVUDINE-ZIDOVUDINE 52 12 37 424
ACARBOSE 50 12 39 643
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.